
    
      3000 patients will be provided with free drug.It is planned to have an interim analysis(IA)
      when 3000 patients are enrolled (cut off day is the 3000th patient completed at least 3
      months follow-up visit). To end or continue enrolling patients will be decided based on the
      IA result and the evaluation comments from CFDA.
    
  